INCY:NASDAQ
Incyte Corp
$126.75
arrow_downward
-0.98%(-1.25) 1D
$126.75
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 4, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$126.46
High
$128.08
Low
$126.04
Mkt. cap
25.69B
Avg. vol.
1.65M
Volume
1.03M
P/E ratio
16.15
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$126.46
High
$128.08
Low
$126.04
Mkt. cap
25.69B
Avg. vol.
1.65M
Volume
1.03M
P/E ratio
16.15
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Incyte stock gains as latest results highlight double digit revenue growth
Zacks
·
1 day ago
Why Is Acadia (ACAD) Up 0.5% Since Last Earnings Report?
Seeking Alpha
·
2 days ago
Incyte Corporation: Why Jakafi Is No Longer The Real Story Here (NASDAQ:INCY)
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEOHervé Hoppenot
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com